Skip to content

Effect of Maharishi Amrit Kalash in Osteoarthritis Patients

Effectiveness of Maharishi Amrit Kalash (MAK) As an Adjunct Therapy with Standard Ayurvedic Treatment in Patients with Osteoarthritis: Open Randomized Clinical Trial; A Pilot Study. - NA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072350
Enrollment
40
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M150- Primary generalized (osteo)arthritis

Interventions

None listed

Sponsors

Maharishi Ayurveda Products Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Osteoarthritis patients with disease duration less than 5 years. 2. Age between 35 to 70 years 3. Both the gender 4. Not taking any Ayurveda medicines for more than one year

Exclusion criteria

Exclusion criteria: 1. Pregnancy and Lactating females 2. Chronic Smokers and alcoholics 3. Chronicity of more than 5 years 4. Having severe crippling deformities 5. Patients undergoing panchakarma treatment 6. Previous intra-articular corticosteroid injections (within 1-2 months) before the study 7. Under any oral corticosteroids 8. Presence of other autoimmune diseases 9. Presence of Diabetes mellitus, Advanced kidney disease cardiovascular, and pulmonary complications 10. Grade 4 knee osteoarthritis in Kellgren-Lawrence grade system

Design outcomes

Primary

MeasureTime frame
1. WOMAC Index WOMAC score involves scoring various aspects of osteoarthritis symptoms, such as pain, stiffness, and physical function, on a numerical scale, allowing for the quantification and measurement of these variables. 2. Pain Disability IndexTimepoint: At baseline, after 1 month, after 2 months and after 3 months

Secondary

MeasureTime frame
Biochemical parameters a) Inflammatory biomarkers hs-Creative Reactive Protein (CRP), Erythrocyte sedimentation rate (ESR), Interleukin - 6 (IL-6) b) Biochemical parameters Complete Blood Count (CBC), Liver Function Test (LFT), Renal Function test (RFT), Glycosylated haemoglobin (HbA1c), Fasting & Post Prandial Blood Glucose (FBG and PPBG) urine test routine.Timepoint: At baseline & after 3 three months;2. Transcriptomics & metagenomicsTimepoint: At baseline & after 3 months

Countries

India

Contacts

Public ContactSmita Dixit

Khosla Medical Institute and Research Society

drsmitadixit@yahoo.com9711224115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026